PO-02-006 Evaluation of sexual functions of female patients using systemic retinoid for acne vulgaris treatment

Abstract

Acne vulgaris is a common skin disease, especially in young adults. The retinoids used in the treatment of acne are the class of chemicals that consist of vitamin A and all its derivatives. Although many side effects related to retinoid treatment have been specified in the literature, there is no study evaluating the effect of this treatment on sexual function, especially in women. The aim of this study is to investigate the effect of retinoid, which is used systemically in the treatment of acne vulgaris, on female sexual functions. Between January 2018 and June 2018, 46 women with acne vulgaris diagnosis and systemic retinoid treatment were included in the study. Medical and sexual history of the patients and physical examination findings were recorded. Global Acne Grading Scale (GAGS) was used to determine the degree of acne. Systemic retinoid therapy was administered (0.5-1.0 mg/kg/day). In each patient, the Female Sexual Function Index (FSFI) and the BECK depression scale were filled before and 2 months after retinoid treatment. Patients with regular sexual intercourse, hormonal disorders, chronic SSRI use and pelvic surgery / radiotherapy history were excluded from the study.